Loading provider…
Loading provider…
Medical Oncology Physician in Saint Louis, MO
NPI: 1023034337Primary Practice Location
BARNES JEWISH HOSPITAL
1 Barnes Jewish Hospital Plz, Saint Louis, MO
Primary Employer
Washington University School of Medicine
surgery.wustl.edu
HQ Phone
Get MD Ravi's Phone Numberphone_androidMobile
Get MD Ravi's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 158 | 637 |
| 2 | 96413Infusion of chemotherapy into a vein up to 1 hour | 145 | 302 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 134 | 308 |
| 4 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 91 | 270 |
| 5 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 73 | 128 |
Authors: Geoffrey Uy, Pavan Kumar Bhamidipati, Mark Schroeder, Peter Westervelt, Amanda Cashen, John Dipersio
Journal: Biol Blood Marrow Transplant
Publication Date: 2017-08-07
Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma.
Authors: Carol Huff, Ajay Nooka, Divaya Bhutani, Terri Parker, Gary Schiller, Rafat Abonour, Jeffrey Zonder, Andrzej Jakubowiak, Sundar Jagannath
Publication Date: 2018-01-31
Racial Disparities in the Utilization of Novel Agents for Frontline Treatment of Multiple Myeloma.
Authors: Fiala, Mark A, Wildes, Tanya M, Vij, Ravi
Journal: Clin Lymphoma Myeloma Leuk
Publication Date: 2020-05-07
Lead Sponsor: Sanofi
Intervention / Treatment: DRUG: dexamethasone, DRUG: lenalidomide, DRUG: isatuximab SAR650984
Lead Sponsor: Sanofi
Intervention / Treatment: DRUG: Isatuximab
Lead Sponsor: Sanofi
Intervention / Treatment: DRUG: Dexamethasone, DRUG: Isatuximab SAR650984